Cover image of the article: The Emerging Extrahepatic Manifestations of Hepatitis C Virus Infection in Chronic Hepatitis and Mixed Cryoglobulinemia

Image Credit:Hepat Mon

The Emerging Extrahepatic Manifestations of Hepatitis C Virus Infection in Chronic Hepatitis and Mixed Cryoglobulinemia

Authors

Poupak Fallahi1, Clodoveo Ferri2, Silvia Martina Ferrari1, Alessandro Pampana1, Domenico Sansonno3, Alessandro Antonelli4,*
1Metabolism Unit, Department of Internal Medicine, University of Pisa, Italy
2Rheumatology Unit, Department of Internal Medicine, University of Modena, Italy
3Department of Internal Medicine and Clinical Oncology, University of Bari, Italy
4Department of Internal Medicine, University of Pisa, School of Medicine, a.antonelli@med.unipi.it, Italy
*Corresponding Author: Department of Internal Medicine, University of Pisa, School of Medicine, a.antonelli@med.unipi.it, Italy. Tel: +39 050 992318. Fax: +39 050 553414. Email: a.antonelli@med.unipi.it

Hepatitis Monthly:Vol. 8, issue 3; 207-211
Published online:Sep 30, 2008
Article type:Review Article
Received:Apr 29, 2008
Accepted:Jul 06, 2008
How to Cite:Fallahi P, Ferri C, Ferrari S, Pampana A, Sansonno D, et al. The Emerging Extrahepatic Manifestations of Hepatitis C Virus Infection in Chronic Hepatitis and Mixed Cryoglobulinemia. Hepat Mon. 2008;8(3):. doi:

Abstract

Hepatitis C virus (HCV) is known to be responsible for both hepatic and extrahepatic diseases. Mixed cryoglobulinemia, Sjögren syndrome, and chronic polyarthritis are the most documented rheumatologic extrahepatic manifestations of HCV infection. The most frequent and clinically important extrahepatic endocrine manifestations of chronic HCV infection are thyroid disorders and type 2 diabetes mellitus. From a meta-analysis of the literature, a significant association between HCV infection and thyroid autoimmunity and/or hypothyroidism as well as a high prevalence of thyroid cancer have been reported. The pattern of thyroid disorders observed in HCV infected patients is characterized by the presence of elevated circulating anti-thyroid peroxidase antibodies with increased risk of hypothyroidism. Several clinical epidemiologic studies have reported that HCV infection is a risk factor for type 2 diabetes. The type of diabetes manifested by subjects with chronic HCV infection is not of the classical type 2 diabetes; in fact, HCV-related diabetic patients are leaner than the classical diabetic patients, and have a significantly lower LDL-cholesterol, and both systolic and diastolic blood pressure. Furthermore, patients with mixed cryoglobulinemia (mixed cryoglobulinemia) and chronic HCV infection with type 2 diabetes have more frequently non-organ-specific-autoantibodies than non-diabetic patients with mixed cryoglobulinemia and those with chronic HCV infection. Based on the above-mentioned findings, it has been hypothesized that diabetes in HCV infection may have an immune-mediated pathogenesis. In patients with chronic HCV infection, we found an increased risk of carotid artery plaque and carotid intima-media thickening. These findings suggested a possible role for chronic hepatitis C in the pathogenesis of carotid artery remodelling. Recently, high prevalence rates of anti-HCV antibodies were shown in patients with hypertrophic cardiomyopathy or dilatated cardiomyopathy; association with myocarditis has also been suggested. Many studies have linked the Th1 immune response with HCV infection, autoimmune thyroid disorders and diabetes. These findings suggest that a possible common immunological Th1 pattern could be the pathophysiological basis of the association.

Highlights

Full Text

Full text is available in PDF

Copyright

© 2008, Author(s). This open-access article is available under the Creative Commons Attribution 4.0 (CC BY 4.0) International License (https://creativecommons.org/licenses/by/4.0/), which allows for unrestricted use, distribution, and reproduction in any medium, provided that the original work is properly cited.

Similar Articles

31
Dec
2008
Autoantibodies in Hepatitis C Virus-Related Chronic Liver Disease

Autoantibodies in Hepatitis C Virus-Related Chronic Liver Disease

Takashi Himoto,
Mikio Nishioka

Himoto T, Nishioka M. Autoantibodies in Hepatitis C Virus-Related Chronic Liver Disease. Hepat Mon. 2008;8(4):. doi:

31
Jan
2006

The Frequency of Non Organ Specific Autoantibodies in Patients with Chronic Hepatitis C and Its Relation with Disease Severity and Response to Therapy

Naser Ebrahimi Daryani,
Hossein Bahrami,
Babak Haghpanah,
Mehdi Jalili,
Aliassad Hashtroudi,
Mohammad Bashashati
,et al.

Ebrahimi Daryani N, Bahrami H, Haghpanah B, Jalili M, Hashtroudi A, et al. The Frequency of Non Organ Specific Autoantibodies in Patients with Chronic Hepatitis C and Its Relation with Disease Severity and Response to Therapy. Arch Clin Infect Dis. 2006;1(1):. doi:

31
Dec
2011
Association of Hepatitis C Virus With Insulin Resistance: Evidences From Animal Studies and Clinical Studie

Association of Hepatitis C Virus With Insulin Resistance: Evidences From Animal Studies and Clinical Studie

Sadaf Badar,
Sadaf Badar,
Bushra Khubaib,
Bushra Khubaib,
Muhammad Idrees,
Muhammad Idrees
,et al.

Badar S, Badar S, Khubaib B, Khubaib B, Idrees M, et al. Association of Hepatitis C Virus With Insulin Resistance: Evidences From Animal Studies and Clinical Studie. Hepat Mon. 2011;12(1):. doi: https://doi.org/10.5812/kowsar.1735143X.807

31
Jan
2012

Hepatitis C Virus Cryoglobulinemia and Non-Hodgkin Lymphoma

Zohreh Jadali,
Zohreh Jadali

Jadali Z, Jadali Z. Hepatitis C Virus Cryoglobulinemia and Non-Hodgkin Lymphoma. Hepat Mon. 2012;12(2):. doi: https://doi.org/10.5812/hepatmon.818

19
Sep
2011
Autoimmune thyroid disorder in patient with chronic hepatitis C before treatment

Autoimmune thyroid disorder in patient with chronic hepatitis C before treatment

Mehr Ali Rahimi,
Babak Sayad,
Ahmad Tahamoli Roudsari,
Karoun Shahebrahimi,
Maria Shirvani,
Mansour Rezaei

Rahimi MA, Sayad B, Tahamoli Roudsari A, Shahebrahimi K, Shirvani M, et al. Autoimmune thyroid disorder in patient with chronic hepatitis C before treatment. J Kermanshah Univ Med Sci. 2011;15(3):e79361. doi:

More by these authors

Poupak FallahiPubMedScholar
Clodoveo FerriPubMedScholar
Silvia FerrariPubMedScholar
Alessandro PampanaPubMedScholar
Domenico SansonnoPubMedScholar
Alessandro AntonelliPubMedScholar
Share
Cited by
Metrics